![]() Argenx Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. | Therapyx Therapyx is a biotechnology company that provides microparticulate immune therapeutics solutions. | ||
Founding Date | Founding Date 2017 | Founding Date 2008 | Founding Date 2001 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Boulder, US HQ | Locations Gent, BE HQ Minato City, JP Breda, NL Genève, CH Boston, US | Locations Buffalo, US HQ |
Employees | Employees 13 | Employees 1,599 | Employees 620% increase |
Funding | |||
Total funding raised | Total funding raised $ 3.4m | Total funding raised $ 396.8m | Total funding raised N/A |

Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer.
View companyTherapyx is a biotechnology company that provides microparticulate immune therapeutics solutions.
View company